CLSL (CLSL) fundamentals
CLSL is a listed company, part of the Agrochemicals sector, listed on the NSE as CLSL (ISIN INE00NH01017). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What CLSL does
Crop Life Science Limited is an India-based company, which manufactures crop protection chemicals. The Company is engaged in the business of manufacturing and dealing in pesticides, insecticides, herbicide, fertilizers, and allied products related to research and technical formulations. It manufactures a diverse range of goods including Insecticides, Fungicides, Herbicides, Micro fertilizers, Bio-Pesticides, BioFertilizers, plant growth regulators, and soil plant health solutions. Its insecticides products include Ladayak, Leothrin, Interex, Imigrow, Rabid, Profkel Super, Larbotin, Tanja-50, ADO 70, Sazedar, Shamsher, Cropdon, Bakhtar, Athoxam, QVIDIC, Hexakill, Armeezin, Astu, Libra, Chhalang, Fencro, Toras, and Mufasa. Its fungicides products include Trovizol, Life Care, Ambucrop, Ibex, Mancostar M-45, Protozone, Thiocrop, Eelaj, Rustblast, Dadubar, and Cyclonex. The Company’s manufacturing plant is located at Ankleshwar, Gujrat.
Valuation and market data
| Last close | ₹83.00 |
|---|---|
| Market capitalisation | ₹142 crore |
| Enterprise value | ₹199 crore |
| P/E (TTM) | 0.00 |
| Price to book | 1.75 |
| Price to sales (TTM) | 0.00 |
| Book value per share | ₹47.50 |
| Dividend yield | 0.00% |
| Sector | Agrochemicals |
| Industry | — |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹209 crore | ₹9 crore | ₹6 crore | 0.00 |
| Mar 2025 | ₹202 crore | ₹8 crore | ₹6 crore | 3.27 |
| Mar 2024 | ₹201 crore | ₹8 crore | ₹6 crore | 3.54 |
| Mar 2023 | ₹132 crore | ₹6 crore | ₹4 crore | 3.39 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Mar 2026:
| Promoters | 70.0% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 0.0% |
| Retail and others | 30.0% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.